Skip to content

Taylor Devices TAYD Risk-free rate

Risk-free rate at other companies

Utah Medical Products logo
Utah Medical ProductsUTMD
3.8%-0.5pp
Ashland logo
AshlandASH
4.3%-0.3pp
Boston Beer logo
Boston BeerSAM
3.4%-0.9pp
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
3.8%
Richardson Electronics logo
Richardson ElectronicsRELL
4.2%+0.2pp
AIR
Air TAIRT
4.1%+3.2pp

Other financials

Income statement

See full
Revenue$11.2M+5.8%
Gross profit$4.5M-0.8%
Operating income$2.3M+14.7%
Net income$2.5M+24.8%
EPS (diluted)$0.72+11.2%

Balance sheet

See full
Cash & equivalents$2.5M+9.9%
Total equity$70.1M+21.4%
Total assets$75.5M+7.6%

Cash flow

See full
Operating cash flow$896.9K-90.1%
CapEx$515.2K+175%
Free cash flow$381.7K-95.7%

Valuation

See full
Market cap$183.65M+38.8%
P/E17.7×+3.6×
P/S3.8×+0.9×

Profitability

See full
Gross margin45.5%-0.8pp
Operating margin21.9%+2.3pp
Net margin21.5%+2.4pp
FCF margin11.6%-13.0pp

Returns & leverage

See full
Return on equity16.2%+0.7pp
Debt / equity
Current ratio11.5×+6.9×

Where this comes from

Reported directly by Taylor Devices in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.

The official record: Taylor Devices’s 10-K, filed August 15, 2025, on SEC EDGAR. View the filing →

Ask your AI about Taylor Devices's risk-free rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Taylor Devices's risk-free rate?
Taylor Devices (TAYD) reported risk-free rate of 3.9% in Q1 2025.
What does risk-free rate mean?
This is the risk-free interest rate used in the valuation models, such as Black-Scholes, to determine the fair value of share-based payment awards granted to employees. It typically corresponds to the yield on government bonds with a maturity matching the expected term of the awards. This input is critical for accurately estimating the compensation expense recognized in the financial statements.